InnoCan Pharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for InnoCan Pharma.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 54.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We're Hopeful That InnoCan Pharma (CSE:INNO) Will Use Its Cash Wisely
Aug 09It's Probably Less Likely That InnoCan Pharma Corporation's (CSE:INNO) CEO Will See A Huge Pay Rise This Year
May 04Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?
Dec 06We Think InnoCan Pharma (CSE:INNO) Can Afford To Drive Business Growth
Aug 15Companies Like InnoCan Pharma (CSE:INNO) Are In A Position To Invest In Growth
Apr 19Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?
Jul 20We Think InnoCan Pharma (CSE:INNO) Needs To Drive Business Growth Carefully
Apr 05In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as InnoCan Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 24 | -4 | -2 | -2 | N/A |
3/31/2024 | 19 | -5 | -4 | -3 | N/A |
12/31/2023 | 14 | -5 | -4 | -4 | N/A |
9/30/2023 | 10 | -5 | -4 | -4 | N/A |
6/30/2023 | 7 | -3 | -5 | -5 | N/A |
3/31/2023 | 4 | -4 | -6 | -6 | N/A |
12/31/2022 | 3 | -4 | -6 | -6 | N/A |
9/30/2022 | 1 | -3 | -7 | -7 | N/A |
6/30/2022 | 1 | -7 | -7 | -7 | N/A |
3/31/2022 | 0 | -6 | -6 | -6 | N/A |
12/31/2021 | 0 | -10 | -7 | -7 | N/A |
9/30/2021 | 0 | -16 | -5 | -5 | N/A |
6/30/2021 | 0 | -14 | -5 | -5 | N/A |
3/31/2021 | 0 | -14 | -5 | -5 | N/A |
12/31/2020 | 0 | -10 | -4 | -4 | N/A |
9/30/2020 | N/A | -3 | -4 | -4 | N/A |
6/30/2020 | N/A | -5 | -3 | -3 | N/A |
3/31/2020 | N/A | -3 | -3 | -3 | N/A |
12/31/2019 | N/A | -3 | -3 | -3 | N/A |
9/30/2019 | N/A | -6 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if INNO's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if INNO's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if INNO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if INNO's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if INNO's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INNO's Return on Equity is forecast to be high in 3 years time